Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Third Line”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Testing effectiveness (Phase 2)UnknownNCT04803851
What this trial is testing

Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer

Who this might be right for
AnlotinibAnti-PD-1 AntibodyAdvanced Pancreatic Cancer
Peking Union Medical College Hospital 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666
What this trial is testing

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

Who this might be right for
Platinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca 600
Testing effectiveness (Phase 2)Study completedNCT01320111
What this trial is testing

Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment

Who this might be right for
Metastatic Breast Cancer
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 59
Large-scale testing (Phase 3)Study completedNCT00088530
What this trial is testing

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
CTI BioPharma 140
Not applicableUnknownNCT05928312
What this trial is testing

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Zhejiang Cancer Hospital 72
Testing effectiveness (Phase 2)UnknownNCT04089072
What this trial is testing

Methylene Blue as a Third-line Vasopressor in Septic Shock

Who this might be right for
Septic Shock
Carilion Clinic 250
Testing effectiveness (Phase 2)UnknownNCT03560856
What this trial is testing

A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer

Who this might be right for
Breast CancerHR+/HER2-negative Breast CancerMetastasis
Assistance Publique - Hôpitaux de Paris 54
Not applicableStudy completedNCT05475431
What this trial is testing

Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity

Who this might be right for
Helicobacter Pylori InfectionComorbidities and Coexisting ConditionsReal-world Outcome+3 more
National Cheng-Kung University Hospital 1,053
Testing effectiveness (Phase 2)Study completedNCT00889057
What this trial is testing

Sorafenib in Relapsed High Grade Osteosarcoma

Who this might be right for
Osteosarcoma
Italian Sarcoma Group 35
Large-scale testing (Phase 3)Study completedNCT02959749
What this trial is testing

Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer

Who this might be right for
Progression Free Survival
Qingdao Central Hospital 147
Testing effectiveness (Phase 2)WithdrawnNCT02522910
What this trial is testing

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Non-Small Cell Lung Cancer)
Yonsei University
Testing effectiveness (Phase 2)UnknownNCT02662959
What this trial is testing

Irinotecan as 3rd Line Therapy in Gastric Cancer

Who this might be right for
Stomach Neoplasms
Fudan University 93
Testing effectiveness (Phase 2)Study completedNCT01553539
What this trial is testing

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Bone CancerChondrosarcomaClear Cell Sarcoma of the Kidney+9 more
Wake Forest University Health Sciences 20
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502014
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)mCRC
Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Ended earlyNCT00442598
What this trial is testing

Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Eleison Pharmaceuticals LLC. 17
Large-scale testing (Phase 3)Study completedNCT03556956
What this trial is testing

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
AB Science 219
Testing effectiveness (Phase 2)UnknownNCT06437678
What this trial is testing

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 50
Not applicableUnknownNCT04768491
What this trial is testing

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Activating MutationNSCLC Stage IVNSCLC Stage IIIB+1 more
Peking Union Medical College 82
Testing effectiveness (Phase 2)UnknownNCT05511051
What this trial is testing

A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Next Page